Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.

Published

Journal Article

Although medulloblastoma is the most common pediatric malignant brain tumor, its molecular underpinnings are largely unknown. We have identified rare, recurrent homozygous deletions of Kruppel-like Factor 4 (KLF4) in medulloblastoma using high-resolution single nucleotide polymorphism arrays, digital karyotyping, and genomic real-time polymerase chain reaction (PCR). Furthermore, we show that there is loss of physiological KLF4 expression in more than 40% of primary medulloblastomas both at the RNA and protein levels. Medulloblastoma cell lines drastically increase the expression of KLF4 in response to the demethylating agent 5-azacytidine and demonstrate dense methylation of the promoter CpG island by bisulfite sequencing. Methylation-specific PCR targeting the KLF4 promoter demonstrates CpG methylation in approximately 16% of primary medulloblastomas. Reexpression of KLF4 in the D283 medulloblastoma cell line results in significant growth suppression both in vitro and in vivo. We conclude that KLF4 is inactivated by either genetic or epigenetic mechanisms in a large subset of medulloblastomas and that it likely functions as a tumor suppressor gene in the pathogenesis of medulloblastoma.

Full Text

Duke Authors

Cited Authors

  • Nakahara, Y; Northcott, PA; Li, M; Kongkham, PN; Smith, C; Yan, H; Croul, S; Ra, Y-S; Eberhart, C; Huang, A; Bigner, D; Grajkowska, W; Van Meter, T; Rutka, JT; Taylor, MD

Published Date

  • January 2010

Published In

Volume / Issue

  • 12 / 1

Start / End Page

  • 20 - 27

PubMed ID

  • 20072650

Pubmed Central ID

  • 20072650

Electronic International Standard Serial Number (EISSN)

  • 1476-5586

Digital Object Identifier (DOI)

  • 10.1593/neo.91122

Language

  • eng

Conference Location

  • United States